본문 바로가기

추천 검색어

실시간 인기 검색어

학술논문

당뇨황반부종의 치료에서 유리체강내 트리암시놀론과 베바시주맙 주입술의 효과 비교

이용수 0

영문명
Comparison of Effects of Intravitreal Triamcinolone and Bevacizumab in the Treatment of Diabetic Macular Edema
발행기관
대한안과학회
저자명
오세범 문준웅 김형찬,Se Beum Oh, MD, Jun Woong Moon, MD, Hyung Chan Kim, MD, PhD
간행물 정보
『대한안과학회지』Ophthalmological Society,volume50,number8, 1190~1196쪽, 전체 7쪽
주제분류
의약학 > 기타의약학
파일형태
PDF
발행일자
2009.08.15
4,000

구매일시로부터 72시간 이내에 다운로드 가능합니다.
이 학술논문 정보는 (주)교보문고와 각 발행기관 사이에 저작물 이용 계약이 체결된 것으로, 교보문고를 통해 제공되고 있습니다.

1:1 문의
논문 표지

국문 초록

영문 초록

Purpose: To compare the effect of an intravitreal injection of triamcinolone acetonide with bevacizumab in the treatment of diabetic macular edema (DME). Methods: For this study, the medical records of patients with diabetic macular edema, who received intravitreal triamcinolone injection (IVTA) or intravitreal bevacizumab injection (IVB), were reviewed. Best corrected visual acuity (BCVA), central macular thickness (CMT) and total macular volume (TMV) were evaluated before injection and at 1 week, 1 month, 2 months, 3 months, and 6 months after injection. The adverse events, such as increased intraocular pressure, and progression of cataract, were also reviewed. Results: A total of 72 eyes from 72 patients, (IVTA: 40 eyes, IVB: 32 eyes) were included in this study. In the IVTA group, BCVA improved significantly at 1 week after injection and was maintained until 3 months after injection. In the IVB group, BCVA improved significantly at 1 week after injection and was maintained until 2 months after injection. In the IVTA group, CMT and TMV decreased significantly at 1 week after injection and were maintained until 3 months after injection, while in the IVB group CMT and TMV were maintained until 2 months after injection. The IVTA group showed significantly better results in visual improvement, CMT and TMV reduction compared to the results of the IVB group, from 1 month to 3 months after injection. In the IVTA group, intraocular pressure increased to more than 25 mmHg in 12.5% of patients during the follow-up period. Conclusions: While the functional and anatomical improvements are achieved by both IVTA and IVB for diabetic macular edema, the effect of IVTA is more prominent with longer duration than IVB.

목차

키워드

해당간행물 수록 논문

참고문헌

교보eBook 첫 방문을 환영 합니다!

신규가입 혜택 지급이 완료 되었습니다.

바로 사용 가능한 교보e캐시 1,000원 (유효기간 7일)
지금 바로 교보eBook의 다양한 콘텐츠를 이용해 보세요!

교보e캐시 1,000원
TOP
인용하기
APA

오세범,문준웅,김형찬,Se Beum Oh, MD, Jun Woong Moon, MD, Hyung Chan Kim, MD, PhD. (2009).당뇨황반부종의 치료에서 유리체강내 트리암시놀론과 베바시주맙 주입술의 효과 비교. 대한안과학회지, 50 (8), 1190-1196

MLA

오세범,문준웅,김형찬,Se Beum Oh, MD, Jun Woong Moon, MD, Hyung Chan Kim, MD, PhD. "당뇨황반부종의 치료에서 유리체강내 트리암시놀론과 베바시주맙 주입술의 효과 비교." 대한안과학회지, 50.8(2009): 1190-1196

결제완료
e캐시 원 결제 계속 하시겠습니까?
교보 e캐시 간편 결제